Lymphocyte Therapy in Treating Patients With Kidney Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1994
RATIONALE: Treating a person\'s lymphocytes with interleukin-2 and monoclonal antibody may help them kill more cancer cells when they are put back in the body. PURPOSE: This phase II trial is studying how well lymphocyte therapy works in treating patients with stage III or stage IV kidney cancer.
Epistemonikos ID: c904dfa8f9c6fc3bba913584233828435e08e82f
First added on: May 03, 2024